✨ Free AI Report
Deep Genomics: Key Facts, Business Model & Financial Analysis Read the overview below or get the full interactive report with Cyborg Score, analyst debate audio & saved-company playlists — free, no credit card.
Get Free Report →
Home Research Preview Deep Genomics
Research Preview

Deep Genomics: Business Overview, Financials & Competitive Analysis

Deep Genomics is an AI-powered platform for RNA biology that accelerates genetic therapy discovery. The company focuses on untangling complex RNA data to identify novel targets and therapeutic candidates for genetic c...

Analyst-debate audio for Deep Genomics

AskCyborg analysts argue the bull and bear cases for Deep Genomics across 11 stress-tested dimensions. Listen on your commute -- faster than reading the 30-page report.

Play the free intro →
Free intro · Pro unlocks the full analyst debate
What's in This Report
Deep Genomics OverviewStrategic ProfileCompetitive LandscapeIndustry ContextKey facts
Get Interactive Report Freeor start reading below
8/ 10Strong

Cyborg Score thesis

Deep Genomics is a capital-efficient, AI-first biotech that is leveraging machine learning to compress drug discovery timelines...

Read the full analyst-debate transcript →
Industry Clinical AI & Drug Discovery
6 named competitors
3 recent developments
11 analyst dimensions
Synthesized from analyst-debate stress-testing across 11 dimensions and hundreds of data points. Methodology →
Cyborg Score recalibrated: October 19, 2026
AI-Generated Research
30+ Page Report

Get the Latest Deep Genomics Report

Up-to-date AI-powered research, analyst debate audio & saved-company playlists

Get Current Report Free
✓ No credit card required
or get it by email

Deep Genomics Overview

Pro stress-test →

Deep Genomics is an AI-powered platform for RNA biology that accelerates genetic therapy discovery. The company focuses on untangling complex RNA data to identify novel targets and therapeutic candidates for genetic conditions, leveraging a proprietary AI platform including its flagship BigRNA model that uses machine learning to analyze vast RNA biology data. This positions Deep Genomics as a pioneer in applying advanced AI to address previously intractable genetic diseases through RNA-based therapeutics.

Strategic Profile

Pro stress-test →

The company's AI platform accelerates early-stage drug discovery and the design of RNA-based therapies. Deep Genomics ranks 9th among 788 active AI-drug discovery competitors and stands 4th in total funding within its competitive set. With significant venture backing and a focused platform approach, the company is positioned as a leading pure-play AI drug discovery platform for rare and genetic diseases where RNA therapeutics can address unmet clinical needs.

Competitive Landscape

Pro stress-test →

Competitors include OneThree Biotech, Caris Life Sciences, Phenomic AI, Genesis Molecular AI, and Stoke Therapeutics. Other notable players in AI drug discovery include Atomwise (University of Toronto-affiliated) and UK-based Exscientia (also SoftBank-backed); Deep Genomics' differentiator is that its AI can program RNA therapy for almost any gene at any genetic position. Deep Genomics is the most focused on RNA-specific drug discovery and design.

Industry Context

Deep Genomics operates in Clinical AI & Drug Discovery.

Key facts

Founded: 2014 · Headquarters: Toronto, Canada · Employees: 108 (as of April 2026) · Revenue: Not publicly disclosed · Market cap: N/A

What the AI analysts debated

AI-generated and not independently verified: selected findings from the multi-agent debate on Deep Genomics.

+1 more AI-generated counter-arguments unlock with Pro. Read the full analyst debate →

Recent developments

Material events tracked by the AskCyborg corpus.

Get alerted when Deep Genomics has a new material development →

Named competitors

Pulled from the analyst-debate framework. Click any competitor to see their Cyborg Score.

AtomwiseAI-driven computational drug discovery and molecular design→ExscientiaAI-powered drug discovery platform for small-molecule therapeutics→Phenomic AIAI-enabled drug discovery targeting phenotypic endpoints→Genesis Molecular AIAI platform for generative molecular design→RecursionComputational platform for drug discovery using machine learning and biology→InceptiveFoundation models for sequence-based medicines including RNA therapies→

Compare Deep Genomics with another company

Pick any company in the AskCyborg corpus to see side-by-side Cyborg Scores and insights.

vs
Side-by-side opens in your AskCyborg account

Industry context

Deep Genomics operates in Clinical AI & Drug Discovery. See how the rest of the sector scores on the Cyborg framework.

Browse Clinical AI & Drug Discovery research →
NEW · MCP server

Ask your AI assistant about Deep Genomics

Install the free AskCyborg MCP server in Claude, Cursor, Cline, Continue, or Windsurf and ask any of these in-line:

“Compare Deep Genomics and its top competitor on Cyborg Score”
“What did Deep Genomics do this quarter?”
“Is Deep Genomics a defensible business in 5 years?”
Install the MCP server (10 sec) →
Free, anonymous, no API key required

How AskCyborg research is made

⚔

AI analyst debate, not single-author opinion

Every report is generated by a panel of AI analysts arguing across 11 dimensions, so counter-arguments sit alongside the case. The debate is a reasoning process; it does not independently verify facts.

📊

Dated, not live

The Cyborg Score and recent developments reflect public sources as of the date shown and can miss or lag recent events. Check primary sources before relying on them.

🔗

Methodology open at /methodology

The framework, dimensions, and band breakdowns are documented. The Cyborg Score is an AI-generated opinion under that framework, not a credit rating or an investment recommendation.

🔒

Free tier is free

No credit card to read the research. Pro adds saved-company audio playlists, monitoring, audio briefings on demand, and PDF export for $39/mo annual.

Sources: public filings, regulatory data, and news flow, analysed by AI models. Read the methodology →

AI-generated research summary based on public sources; it may contain errors or omissions. Not investment advice. Not reviewed or endorsed by the companies covered. Report an error: legal@askcyborg.com (you must copy support@askcyborg.com) · Terms of Service

Frequently asked questions

What does Deep Genomics do?+
Deep Genomics is an AI-powered platform for RNA biology that accelerates genetic therapy discovery. The company focuses on untangling complex RNA data to identify novel targets and therapeutic candidates for genetic c...
What is Deep Genomics's Cyborg Score?+
Deep Genomics has a Cyborg Score of 8/10 (Strong). The score synthesizes business model, financials, leadership, competitive position, technology, marketing, and ESG dimensions across hundreds of data points.
Who are Deep Genomics's main competitors?+
Named competitors include Atomwise, Exscientia, Phenomic AI, Genesis Molecular AI. The full competitive landscape is in the AskCyborg report.
How can I get the full Deep Genomics research report?+
Get the report plus analyst-debate audio at askcyborg.com -- no credit card required for preview access. Pro adds saved-company audio playlists and monitoring.
How current is the Deep Genomics research?+
The Cyborg Score is recalibrated weekly. Recent developments are tracked continuously and surfaced in every report.

Track Deep Genomics over time

Pro members get saved-company audio playlists, Cyborg Score recalibrations, and monitoring for material events across the AskCyborg corpus.

See Pro features
From $39/mo annual

Top-scored companies on AskCyborg

The strongest performers across the analyst-debate framework.

9Advantest Corporation9Anthropic9Apple Inc.9Applied Materials, Inc.9Arista Networks9Aritzia Inc.9ASML Holding N.V.9BAE Systems plc9Barrick Mining Corporation9Berkshire Hathaway Inc.